| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $320K | +24.4% |
| Cost of Revenue | $101K | -96.6% |
| Gross Profit | $219K | -95.7% |
| R&D Expense | $588K | -67.4% |
| SG&A Expense | $2.4M | +163.3% |
| Operating Income | -$10.5M | -35.3% |
| Net Income | -$10.3M | -43.9% |
| EPS (Basic) | -$4.86 | +64.9% |
| EPS (Diluted) | -$4.86 | +64.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.0M | +619.0% |
| Accounts Receivable | $325 | -100.0% |
| Current Assets | $5.4M | +18.5% |
| Total Assets | $6.5M | +35.6% |
| Current Liabilities | $2.7M | -45.1% |
| Total Liabilities | $2.7M | -45.8% |
| Stockholders' Equity | $3.8M | +1587.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.7M | +15.3% |
| Investing Cash Flow | $315 | +0.0% |
| Financing Cash Flow | $8.7M | +1178.4% |